Join Calluna Pharma on our mission to revolutionize the treatment of inflammatory and fibrotic diseases. With a robust pipeline, seasoned leadership, and strategic alliances, help us reshape the treatment landscape for the better.
Total raised: $81.93M
Investors 2
Date | Name | Website |
24.01.2024 | Forbion | forbion.co... |
02.04.2024 | Sarsia | sarsia.com |
Funding Rounds 1
Date | Series | Amount | Investors |
24.01.2024 | Series A | $81.93M | Forbion |
Mentions in press and media 4
Date | Title | Description | Source |
24.01.2024 | Calluna Pharma Raises €75M in Series A Financing | Calluna Pharma, an Oslo, Norway-based clinical stage company formed from the merger of Oxitope Pharm... | finsmes.co... |
23.01.2024 | Forbion announces 75 million EUR Series A financing in Callu... | • Clinical stage company formed from the merger of Oxitope Pharma and Arxx Therapeutics to develop n... | forbion.co... |
23.01.2024 | Calluna Pharma launches and announces EUR 75 million Series ... | · Clinical stage company formed from the merger of Oxitope Pharma and Arxx Therapeutics · Calluna Ph... | cambridgen... |
- | Calluna Pharma | “Join Calluna Pharma on our mission to revolutionize the treatment of inflammatory and fibrotic dise... | fastfounde... |